Amsterdam Investigator–initiateD Absorb strategy all-comers trial (AIDA trial): A clinical evaluation comparing the efficacy and performance of ABSORB.

Slides:

Advertisements

Similar presentations

Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary.

Advertisements

Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.

Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial Bruce.

Effects of β-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal.

Evaluation of XIENCE V Everolimus-Eluting and Taxus Express2 Paclitaxel-Eluting Coronary Stents in Patients With Jailed Side Branches From the SPIRIT.

Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST) Kirsten E. Fleischmann,

An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist.

Downstream coronary effects of drug-eluting stents

Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting on the Edwards SAPIEN.

Quality of life and chronic heart failure therapy guided by natriuretic peptides: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy.

Routine invasive management early after fibrinolysis: Relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7.

Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD)

Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E

Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve.

Clinical value of post–percutaneous coronary intervention fractional flow reserve value: A systematic review and meta-analysis Goran Rimac, MD, William.

Rationale and design of the PRAETORIAN trial: A Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator.

Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: A comparison of fractional flow reserve–guided.

American Heart Journal

American Heart Journal

The outcome of primary percutaneous coronary intervention for stent thrombosis causing ST-elevation myocardial infarction Mehmet Ergelen, MD, Sevket.

Evaluation of a novel anti-ischemic agent in acute coronary syndromes: Design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia.

CHronic use of Amiodarone aGAinSt Implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy.

Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: One-year follow-up results.

Neutral impact on systolic and diastolic cardiac function of 2 years of intensified multi- intervention in type 2 diabetes: The randomized controlled Asker.

Rationale and design of the FreezeAF trial: A randomized controlled noninferiority trial comparing isolation of the pulmonary veins with the cryoballoon.

Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study.

Variation among hospitals in selection of higher-cost, “higher-tech,” implantable cardioverter-defibrillators: Data from the National Cardiovascular Data.

Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease Ralf.

BRS Next Large Trials: What is on the Horizon?

Rationale and design of the ATTRACT Study: A multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention.

Evaluating the safety and efficacy of sodium-restricted/Dietary Approaches to Stop Hypertension diet after acute decompensated heart failure hospitalization:

Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice Manesh R.

Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular.

Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: An open-label, blinded end point, randomized.

Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective.

A multifaceted intervention to narrow the evidence-based gap in the treatment of acute coronary syndromes: Rationale and design of the Brazilian Intervention.

Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: The.

Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting.

Put a Face to a Name: A Randomized Controlled Trial Evaluating the Impact of Providing Clinician Photographs on Inpatients' Recall Lora Appel, PhDc,

Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous leishmania major infection: A randomized.

Development of Clinical Practice Guidelines in the Care of People With Kidney Disease: Core Curriculum 2016 Angela C. Webster, PhD, Evi V. Nagler, MD,

Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure

Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease Ralf.

Impact of 64-Slice Multidetector Computed Tomography on Other Diagnostic Studies for Coronary Artery Disease Alex J. Auseon, DO, Sunil S. Advani, MD,

Standardizing definitions for hybrid coronary revascularization

A Randomized, Double-Blind, Placebo-Controlled Trial of Nutritional Supplementation During Acute Illness Salah Gariballa, MD, Sarah Forster, MSc, Stephen.

First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease Johannes Lammer, MD, Marc.

C-reactive protein and coronary events following percutaneous coronary angioplasty Robbert J de Winter, MD, PhD, Karel T Koch, MD, PhD, Jan P van Straalen,

Peter M. Farrehi, MD, Kristen R. Clore, OTRL, J

Badrul A. Chowdhury, MD, PhD

Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease

Reply to: “Comment on ‘Activation of melanocytes in idiopathic guttate hypomelanosis after 5-fluorouracil infusion using a tattoo machine: Preliminary.

(p = 0.32 for noninferiority)

Ronak Delewi, Wieneke Vlastra, Wim J. Rohling, Tineke C

Salt and Hypertension American Journal of Kidney Diseases

Redefining Appropriate Treatment Expectations

Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE.

Is There Any Reason to Stent Atherosclerotic Renal Artery Stenosis?

Severe Constipation Clinical Gastroenterology and Hepatology

Evaluation of toe pressure and transcutaneous oxygen measurements in management of chronic critical leg ischemia: a diagnostic randomized clinical trial

A review of the current guidelines for allergic rhinitis and asthma

Use of Diuretics in Heart Failure: A Precarious Balance

Study Designs in Patient-Oriented Research

Guidelines should bother us, not comfort us

Trial Quality in Nephrology: How Are We Measuring Up?

Volume 11, Issue 1, (February 2013)

(p for non-inferiority < 0.001)

Dialysis Research and N-of-1 Trials: Made for Each Other?

Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani Erwin Suys, MD Journal of the American Academy.

Prospective randomized study evaluating an absorbable cyanoacrylate for use in vascular reconstructions Alan B. Lumsden, MD, Eugene R. Heyman, PhD Journal.

Presentation transcript:

Amsterdam Investigator–initiateD Absorb strategy all-comers trial (AIDA trial): A clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: Rationale and study design Pier Woudstra, MD, Maik J. Grundeken, MD, Robin P. Kraak, MD, Mariëlla E.C.J. Hassell, MD, E. Karin Arkenbout, PhD, MD, Jan Baan, PhD, MD, Marije M. Vis, PhD, MD, Karel T. Koch, MD, PhD, Jan G.P. Tijssen, PhD, Jan J. Piek, MD, PhD, Robbert J. de Winter, MD, PhD, José P.S. Henriques, MD, PhD, Joanna J. Wykrzykowska, MD, PhD American Heart Journal Volume 167, Issue 2, Pages 133-140 (February 2014) DOI: 10.1016/j.ahj.2013.09.017 Copyright © 2014 Mosby, Inc. Terms and Conditions

Figure 1 Enrollment scheme. In the case of emergency PCI, the patient provides oral consent before randomization and written consent for the follow-up trial procedures is obtained after the procedure. Full written informed consent is mandatory before the procedure in the case of elective PCI. If patients are not enrolled in the study, they are anonymized registered into a screening log. ID, identification; IWRS, Interactive Web Response System; QOL, quality of life. American Heart Journal 2014 167, 133-140DOI: (10.1016/j.ahj.2013.09.017) Copyright © 2014 Mosby, Inc. Terms and Conditions

Figure 2 Follow-up scheme. *The XIENCE family is composed of the XIENCE PRIME and XIENCE Xpedition stents. †The Quality of Life questionnaires taken are the EQ-5D and SAQ. If patients are enrolled in the study, follow-up is obtained up to 5 years after the index procedure by telephone contact or a scheduled outpatient clinic visit. Both at 1 year and at 2 years of follow-up, the Quality of Life questionnaires are taken by all participating subjects. American Heart Journal 2014 167, 133-140DOI: (10.1016/j.ahj.2013.09.017) Copyright © 2014 Mosby, Inc. Terms and Conditions